Growth & profitability
- Revenue has grown 77.3% per year over the past 5 years.
Financial health
- Total debt has grown slower than revenue (27.6% vs 77.3% per year).
- Operating income covered interest expense -98.6× in the latest year.
8 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $11M | -$3M | 39.5% | -29.3% | -$1M | $588000 | — |
| 2024 | $9M | -$3M | 31.6% | -40.9% | -$4M | $685000 | — |
| 2023 | $4M | -$3M | 9.1% | -85.0% | -$4M | $838000 | — |
| 2022 | $2M | -$5M | 12.5% | -163.5% | -$3M | $283000 | — |
| 2021 | — | -$4M | — | — | -$3M | — | $13M |
| 2020 | — | -$2M | — | — | -$2M | — | $32000 |
| 2019 | — | -$2M | — | — | -$2M | — | $261000 |
| 2018 | — | -$2M | — | — | — | — | $0 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $3M | -$927000 | 40.0% | -36.2% | -$513000 | $563000 | $2M |
| Dec '25 | $3M | -$970000 | 29.3% | -43.4% | — | $588000 | — |
| Sep '25 | $3M | -$653000 | 42.4% | -24.7% | -$793000 | $614000 | $2M |
| Jun '25 | $3M | -$665000 | 43.6% | -22.1% | — | $638000 | — |
| Mar '25 | $3M | -$712000 | 42.3% | -27.7% | — | $662000 | $1M |
| Dec '24 | $3M | -$850000 | 35.3% | -27.7% | — | $685000 | — |
| Sep '24 | $3M | -$693000 | 39.3% | -26.8% | -$1M | $1M | $1M |
| Jun '24 | $1M | -$885000 | 20.3% | -73.2% | -$909000 | $732000 | — |
| Mar '24 | $1M | -$853000 | 12.6% | -68.8% | -$1M | $750000 | — |
| Dec '23 | $1M | -$1M | -8.0% | -112.7% | — | $838000 | — |
| Sep '23 | $1M | -$550000 | 28.2% | -50.1% | -$1M | $368000 | — |
| Jun '23 | $1M | -$695000 | 15.0% | -65.3% | -$1M | $280000 | — |
| Mar '23 | $620000 | -$814000 | -9.2% | -142.4% | -$797000 | $281000 | — |
| Dec '22 | — | -$648000 | — | — | — | $283000 | — |
| Sep '22 | — | -$1M | — | — | -$905000 | — | — |
| Jun '22 | — | -$1M | — | — | -$729000 | — | $4M |
| Mar '22 | — | -$2M | — | — | -$797000 | — | $11M |
| Dec '21 | — | -$2M | — | — | — | — | $13M |
| Sep '21 | — | -$1M | — | — | -$646000 | — | $1M |
| Jun '21 | — | -$825000 | — | — | -$688000 | — | $382000 |
How the market has priced NXGLW against its own fundamentals since 2023-04 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, NEXGEL, INC.'s revenue has grown 77.3% per year. These are computed facts, not advice.
As of FY2025, NEXGEL, INC. reported $588000 of total debt against — of cash; operating income covered interest expense -98.6×.
In FY2025, gross margin was 39.5%, operating margin -29.3%, and net margin -26.3%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.